MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 drug alert for Accord’s Digoxin BP tablets 250mg.

Digoxin is prescription only medicine and is indicated for the treatment of congestive cardiac failure.

“Accord-UK Ltd has informed us of an issue related to decommissioning of a specific batch. Upon decommissioning at the pharmacy, there have been reports stating that when scanning the serialised 2D code, the status of the packs may report as ‘export’, the MHRA said in a statement.

The regulator has advised that although there is no risk to product quality, any remaining stock should be quarantined and returned.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY